openPR Logo
Press release

Prostate Cancer Drug Market Share Report by Renub Research

05-09-2017 02:29 PM CET | Health & Medicine

Press release from: Renub Research

Zytiga has highest market share in Prostate Cancer Market share globally. Zytiga is facing hard fight from Xtandi drugs which is anticipated to substitute Zytiga as the primary prostate cancer drugs in 2015. Zytiga was one of a small number of treatment choices for patients suffering from prostate cancer. This shows that most doctors prefer to treat patients with Zytiga drug despite its side effects. Before September 10, 2014 Xtandi, was given to only those patients who have previously received chemotherapy. But after September 10, 2014, Xtandi was permitted to be used as treatment choice for pre–chemotherapy prostate cancer patients.

Out of 15 Prostate Drugs Market share only 4 drugs (Zytiga, Zoladex, Leuplin & Xtandi or MDV3100) have double digit market share in prostate cancer drugs market. All these four drugs together account for more than 60 percent market share. Zytiga market share is more than double from its nearest competitor Leuplin.

There are various prostate cancer treatments available for a man such as Surgery, Radiation, Hormone Therapy, Chemotherapy, Biologic therapy and Bisphosphonate therapy.

Surgery: In this doctor removes a certain part of prostate, the operation depends on the size of tumor.

Radiation: In this cure high-energy waves are used by doctors to reduce the size of tumor and kill cancer cells.

Hormone Therapy: Patients body makes few hormones which stimulates the size of prostate cancer cells. This treatment reduces the levels of hormones in the patient’s body.

Chemotherapy: In this treatment drugs are given through a mouth or an IV for removing cancer cells and reducing the size of tumors. A patient gets chemotherapy, when the cancer spreads outside prostate and hormone therapy is not showing any result.

Biologic Therapy: This therapy works along patient’s immune system, it’s used in cases of advanced prostate cancer.

For More Information: http://www.renub.com/prostate-cancer-market-prostate-cancer-drugs-market-share-zytiga-gonax-lupron-zoladex-decapeptyl-eligard-vantas-leuplin-casodex-xtandi-mdv3100-taxotere-14-nd.php

Bisphosphonate therapy: In cases when disease reaches patients bones then these drugs are being given to get relieve from pain and stop fractures.
Market research report “Global Prostate Cancer Therapeutics Market to 2020” studies prostate cancer market, incidences and its drugs market. 15 Prostate Cancer Drugs Market have been studied in the report:

Zytiga
Gonax
Lupron
Zoladex
Decapeptyl
Eligard
Vantas
Leuplin
Casodex
Xtandi or MDV3100
Xtandi US or MDV3100
Taxotere
Jevtana
Provenge
Xofigo or Alpharadin

Renub Research is a leading Market Research and Information Analysis Company with centers at Noida India and Roswell USA. We have long-term experience especially in international Business-to-Business Researches, Surveys, Business and Consulting. Throughout the years we have acquired expertise in most market sectors, including Information Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer Goods, Logistics, Governmental, Social, and Others.

Our core team is comprised of an experienced people holding graduate, post graduate and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research help make the business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in today’s ultra-competitive markets.

225 Kristie Ln, Roswell, GA 30076, United States

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Prostate Cancer Drug Market Share Report by Renub Research here

News-ID: 528789 • Views: 166

More Releases from Renub Research

China Dairy Market will reach US$ 176 Billion by 2026
According to the latest report by Renub Research, titled "China Dairy Market & Forecast by Type (Liquid Milk, Milk Powder, Other), Product, Production & Consumption Volume, Import, Export Volume, & Company Analysis" The China dairy market is growing year on year, over the last few decades; the country has been one of the world's leading consumers of milk. With the rise in per capita income annually, dairy consumption has increased
Russia Online Education Market will be US$ 2 Billion by 2026
According to the latest report by Renub Research, titled "Russia Online Education Market by Segment (Elementary, Central Secondary, Supplementary School, Higher, Secondary & Supplementary Vocational, Language Training) Company Analysis" Edtech's spread is causing significant improvements to Russia's education system. The online education market in Russia has grown with double-digit CAGR in recent years. According to the Renub Research report, Russia Online Education Market will be more than US$ 2 Billion
Paper Packaging Market By Product Type, & Companies
Paper and based materials are the most established and most adaptable types of packaging materials accessible in today’s life. Paper is an extremely flexible material. It is produced from cellulosic, mostly from naturally renewable fibres obtained from wood and recycled waste paper pulp. It is thus considered as an ecologically well disposed of, being easily recycled. Globally, Paper and paperboard have the highest recycling rates. According to Renub Research analysis,
Cassava Starch Market, Consumption & Global Forecast by Product
Cassava is the increasingly popular feed material for starch extraction. Cassava is the oldest source for starch, after maize, wheat or potato. Cassava leaves have the healthiest form of protein and beta-carotenoids, are also used as a vegetable and forage in the world. Cassava raw material is a relatively inexpensive source for starch, which has three types: native, modified & sweetener. The cassava starch market will represent a considerable CAGR

All 5 Releases


More Releases for Zytiga

Cancer Therapeutics Market Growing $178,863 Million By 2023
The use of targeted, biologic (immunotherapy) & other forms of therapies administered to treat cancer through oncology drugs is known as cancer therapeutics. The global cancer therapeutics market was valued at $81,291 million in 2016 and is estimated to reach at $178,863 million by 2023, registering a CAGR of 11.9% from 2017 to 2023. For More Info, Get Sample : https://www.researchbeam.com/cancer-therapeutics-biotherapeutic-market/request-sample Upsurge in collaboration between pharmaceutical companies,
Global Prostate Cancer Therapeutics Market To 2020
Global Prostate Cancer Therapeutics Market Overview The prostate cancer drugs market is expected to nearly double by 2020, due to the introduction of new, more expensive drugs. Prostate Cancer is the most frequently diagnosed cancer in men. In terms of loss of life from any disease, prostate cancer ranks eleventh; and it ranks sixth in terms of cancer–related mortality in men. The prostate cancer market has a huge demand for new
Prostate Cancer Therapeutics Market is Slated to Increasing Rapidly Owing to Pro …
Prostate cancer is among serious health issue among men has large socioeconomic impact on the society. It is the most common cancer diagnosed among men in developed regions, while it is sixth most common cancer diagnosed in less developed nations. Routine screening, early diagnosis, and recent treatment options have enabled increased survival of prostate cancer patients. Download Exclusive Sample of this Report: http://bit.ly/2eIix2x Prostate cancer is an abnormal and uncontrolled growth of
Prostate Cancer Therapeutics Market Size, Share, Growth, Trends and Forecast 201 …
Prostate cancer is among serious health issue among men has large socioeconomic impact on the society. It is the most common cancer diagnosed among men in developed regions, while it is sixth most common cancer diagnosed in less developed nations. Routine screening, early diagnosis, and recent treatment options have enabled increased survival of prostate cancer patients. Prostate cancer is an abnormal and uncontrolled growth of cells in prostate gland of
10-05-2016 | Health & Medicine
RMOZ
Drugs for Treatment of Prostate Cancer in America, Established ROW, Emerging Mar …
"China, Russia, Brazil and Japan Drugs for Treatment of Prostate Cancer Research Report 2015 to 2021". The Report covers current Market Trends, Analysis, Forecast, Review, Share, Size, Growth, Effect. -Description- The global Drugs for Treatment of 'Prostate Cancer' market was valued at USD 30.41 Billion in 2015, and is projected to reach USD 35.26 Billion by 2021, at a CAGR of 59.49% between 2016 and 2021. The market is
Prostate Cancer Treatment to Revolutionize Standard of Care and Multiple Treatme …
Prostate cancer is among serious health issue among men has large socioeconomic impact on the society. It is the most common cancer diagnosed among men in developed regions, while it is sixth most common cancer diagnosed in less developed nations. Routine screening, early diagnosis, and recent treatment options have enabled increased survival of prostate cancer patients. Prostate cancer is an abnormal and uncontrolled growth of cells in prostate gland of